文献速递白内障与屈光手术

18年前瞻性审计:53,731眼近视LASIK手术结局

Eighteen-year prospective audit of LASIK outcomes for myopia in 53 731 eyes.
PubMed 文献 · Br J Ophthalmol · 2018-10-24

BACKGROUND: To assess the outcomes of laser-assisted in situ keratomileusis (LASIK) performed for the treatment of myopia in terms of safety, efficacy and predictability in an 18-year clinical audit.…

要点

  • 自2010年起,超过99%眼术后裸眼视力≥20/40,超过70%达20/20。
  • 95.43%眼无视力丢失,4.2%丢失1行,0.37%丢失≥2行最佳矫正视力。
  • 总体并发症率0.98%,2010年后年并发症率<0.8%。

核心结论

  • 在具备适当临床审计的综合LASIK项目中,亚洲眼近视LASIK安全有效且屈光预测性高。

研究设计与样本

  • 记录术前术后屈光度、裸眼视力、最佳矫正Snellen视力及并发症,评估安全性、有效性、屈光预测性、治疗趋势、再治疗率和并发症率。

主要发现

  • 患者中位年龄31.6岁(均值32.6±7.3岁),男性9703例(35.5%),以华裔为主(87.4%),平均随访78±75.6天(中位86天)。
  • 总体疗效指数0.91;自2010年起,超过99%眼裸眼视力≥20/40,超过70%达20/20。
  • 95.43%眼无视力丢失,4.2%丢失1行、0.37%丢失≥2行最佳矫正视力;自2010年起安全指数>1.05。
  • 超过94.0%眼术后屈光度在目标值±1.0 D以内,自2010年起至少70%在±0.50 D以内。
  • 再治疗率2.55%,再治疗后98.4%眼裸眼视力≥20/40、63.5%≥20/20;总体并发症率0.98%,自2010年起年并发症率<0.8%。

关键数值与推荐

  • 自2010年起疗效指标:超过99%眼裸眼视力≥20/40,超过70%达20/20。
  • 自2010年起安全指数>1.05;屈光预测性:超过94.0%眼在±1.0 D内,至少70%在±0.50 D内。
  • 再治疗率2.55%,再治疗后98.4%眼裸眼视力≥20/40、63.5%≥20/20。
  • 总体并发症率0.98%,自2010年起年并发症率<0.8%。

临床怎么用

  • 近视LASIK在亚洲眼中安全有效,屈光预测性高,适合在具备临床审计的综合项目中开展。
  • 术后裸眼视力和屈光预测性随时间改善,2010年后指标更优,提示技术或流程优化带来获益。
  • 再治疗率较低且再治疗后视力良好,并发症率低,支持其作为近视矫正的可靠选择。

局限性

  • 单中心、非随机设计,结果外推需谨慎。
  • 平均随访时间较短(78±75.6天),缺乏长期结局数据。
  • 患者以华裔为主(87.4%),人群代表性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To assess the outcomes of laser-assisted in situ keratomileusis (LASIK) performed for the treatment of myopia in terms of safety, efficacy and predictability in an 18-year clinical audit. METHOD: In this single-centre, prospective, non-randomised study, preoperative and postoperative refractions, uncorrected (UCVA), best-corrected Snellen visual acuity (BCVA) and complications of all eyes undergoing myopic LASIK were recorded. Safety, efficacy, refractive predictability, treatment trends, retreatment rates and complication rates were evaluated. RESULTS: Between 1998 and 2015, 53 731 eyes of 27312 patients underwent myopic LASIK. Patients' median age was 31.6 years (mean, 32.6±7.3 years); there were 9703 males (35.5%). Patients were predominantly ethnic Chinese (87.4%). Mean follow-up time was 78±75.6 days (median, 86 days). Overall efficacy index was 0.91 with >99% of eyes achieving UCVA of ≥20/40 and >70% achieving 20/20 since 2010. 95.43% of eyes had no loss of vision postoperatively and 4.2% and 0.37% lost 1 and ≥2 lines BCVA, respectively. From 2010 the safety index has been >1.05. More than 94.0% of eyes achieved within ±1.0 D of target refraction and at least 70% achieved within ±0.50 D of target from 2010 onwards. Retreatment rate was 2.55% and after retreatment 98.4% of eyes achieved ≥20/40 UCVA and 63.5% achieved ≥20/20 UCVA. The overall complication rate is 0.98%, and since 2010, the annual complication rate has been <0.8%. CONCLUSIONS: Myopic LASIK performed in Asian eyes is safe and effective with high refractive predictability in a comprehensive LASIK programme with appropriate clinical audit.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Chua D, Htoon HM, Lim L, et al. Eighteen-year prospective audit of LASIK outcomes for myopia in 53 731 eyes. Br J Ophthalmol. 2018. PMID: 30355717. doi:10.1136/bjophthalmol-2018-312587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。